PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pulmonary and Critical Care Medicine.\', \'Infectious Disease, and.\', \'Infectious Disease.\', \'Infectious Disease, Stanford University, Stanford, California; and.\', \'Hospital Medicine, Intermountain Medical Center, Murray, Utah.\', \'Pharmacy Services and.\', \'Inpatient Medicine, Department of Pediatrics.\', \'Healthcare Delivery Institute, Intermountain Healthcare, Murray, Utah.\', \'Hospital Medicine, and.\', \'Biostatistics, University of Utah, Salt Lake City, Utah.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1513/AnnalsATS.202004-309SD
?:doi
?:hasPublicationType
?:journal
  • Annals of the American Thoracic Society
is ?:pmid of
?:pmid
?:pmid
  • 32425051
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.797
?:rankingScore_hIndex
  • 95
?:title
  • Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all